Impax Laboratories Inc (NASDAQ:IPXL)

40.08
Delayed Data
As of Mar 05
 -0.32 / -0.79%
Today’s Change
22.12
Today|||52-Week Range
41.39
+26.52%
Year-to-Date

Today’s Trading

Previous close40.40
Today’s open40.60
Day’s range39.84 - 41.08
Volume411,544
Average volume (3 months)675,638
Market cap$2.9B
Dividend yield--
Data as of 4:00pm ET, 03/05/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+4.07%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+16.53%
P/E ratio49.3
Price/Sales3.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
WXWuxi Pharmatech Caym...+0.26+0.64%
HZNPHorizon Pharma PLC-0.33-1.56%
CLVSClovis Oncology Inc+2.26+2.92%
MYGNMyriad Genetics Inc+0.49+1.43%
Data as of 4:02pm ET, 03/05/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.15
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account